HKU identifies rare, actionable pharmacogenetic variants specific to Hong Kong/Southern Chinese
13 Apr 2021
byNatalia Reoutova
After analyzing 108 pharmacogenes from the largest set of exome sequencing data from Chinese subjects to date, researchers from the University of Hong Kong (HKU) have identified 96 rare, previously unreported deleterious variants with actionable potential in clinical practice.
HKU identifies rare, actionable pharmacogenetic variants specific to Hong Kong/Southern Chinese
13 Apr 2021